-
1
-
-
2342466407
-
-
American Cancer Society Website. Cancer Statistics 2004. www.acs.org.
-
(2004)
Cancer Statistics
-
-
-
2
-
-
0141688377
-
Phase III trial of carboplatin and paclitaxel compared to cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
-
Ozols RF, Bundy BN, Greer BE, et al. Phase III trial of carboplatin and paclitaxel compared to cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21:3194-3200.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3194-3200
-
-
Ozols, R.F.1
Bundy, B.N.2
Greer, B.E.3
-
3
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334:1-6.
-
(1996)
N Engl J Med
, vol.334
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
-
4
-
-
0038690538
-
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxed in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A southwest oncology group and gynecologic oncology group trial
-
Markman M, Liu PY, Wilczynski S, et al. Phase III randomized trial of 12 versus 3 months of maintenance paclitaxed in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a southwest oncology group and gynecologic oncology group trial. J Clin Oncol 2003; 21:2460-2465.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2460-2465
-
-
Markman, M.1
Liu, P.Y.2
Wilczynski, S.3
-
5
-
-
4644354408
-
Timing isn't everything: An analysis of when to start salvage chemotherapy in ovarian cancer
-
McMeekin DS, Tillmanns T, Chaudry T, et al. Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer. Gynecol Oncol 2004; 95:157-164. Retrospective trial analyzing the experience of patients with CCR who received salvage chemotherapy at recurrence. Inferences are made to GOG 178 with regards to timing of salvage therapy.
-
(2004)
Gynecol Oncol
, vol.95
, pp. 157-164
-
-
McMeekin, D.S.1
Tillmanns, T.2
Chaudry, T.3
-
6
-
-
0037862963
-
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial
-
The ICON, Collaborators AGO. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 2003; 361:2099-2105.
-
(2003)
Lancet
, vol.361
, pp. 2099-2105
-
-
-
7
-
-
0026720218
-
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
-
Hakes TB, Chalas E, Hoskins WJ, et al. Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. Gynecol Oncol 1992; 45:284-289.
-
(1992)
Gynecol Oncol
, vol.45
, pp. 284-289
-
-
Hakes, T.B.1
Chalas, E.2
Hoskins, W.J.3
-
8
-
-
0027276217
-
A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: A Danish Ovarian Study Group Trial
-
Bertelsen K, Jakobsen A, Stroyer I, et al. A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: A Danish Ovarian Study Group Trial. Gynecol Oncol 1993; 49:30-36.
-
(1993)
Gynecol Oncol
, vol.49
, pp. 30-36
-
-
Bertelsen, K.1
Jakobsen, A.2
Stroyer, I.3
-
9
-
-
30444431612
-
A randomized study of epithelial ovarian cancer: Is chemotherapy useful after complete remission?
-
Nicoletto MO, Tumolo S, Falci C, et al. A randomized study of epithelial ovarian cancer: is chemotherapy useful after complete remission? Int J Med Sci 2004; 1:116-125. Randomized clinical trial comparing observation to maintenance chemotherapy with sequential 5-FU and cisplatin.
-
(2004)
Int J Med Sci
, vol.1
, pp. 116-125
-
-
Nicoletto, M.O.1
Tumolo, S.2
Falci, C.3
-
10
-
-
20444470006
-
Consolidation therapy with weekly paclitaxed infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: An extended follow-up
-
Skinner EN, Boruta DM, Gehrig PG, et al. Consolidation therapy with weekly paclitaxed infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: An extended follow-up. Gynecol Oncol 2005; 98:59-62.
-
(2005)
Gynecol Oncol
, vol.98
, pp. 59-62
-
-
Skinner, E.N.1
Boruta, D.M.2
Gehrig, P.G.3
-
11
-
-
1242320050
-
Consolidation therapies revisited: Weekly paclitaxel
-
Pecorelli S, Odicino F, Favalli G. Consolidation therapies revisited: weekly paclitaxel. Int J Gynecol Cancer 2003; 13 (Suppl 2):208-211.
-
(2003)
Int J Gynecol Cancer
, vol.13
, Issue.2 SUPPL.
, pp. 208-211
-
-
Pecorelli, S.1
Odicino, F.2
Favalli, G.3
-
12
-
-
2042487233
-
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the South west Oncology Group
-
Alberts DS, Jiang C, Liu PY, et al. Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the South west Oncology Group. Int J Gynecol Cancer 2004; 14:224-228.
-
(2004)
Int J Gynecol Cancer
, vol.14
, pp. 224-228
-
-
Alberts, D.S.1
Jiang, C.2
Liu, P.Y.3
-
13
-
-
4344678332
-
Topotecan compared with no therapy after response to surgery and carboplatin/Paclitaxel in patients with ovarian cancer: Multicenter Italian trials in ovarian cancer (MITO-1) randomized study
-
De Placido S, Scambia G, Di Vagno G, et al. Topotecan compared with no therapy after response to surgery and carboplatin/Paclitaxel in patients with ovarian cancer: multicenter Italian trials in ovarian cancer (MITO-1) randomized study. J Clin Oncol 2004; 22:2635-2642. Randomized clinical trial comparing observation to maintenance chemotherapy with topotecan.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2635-2642
-
-
De Placido, S.1
Scambia, G.2
Di Vagno, G.3
-
14
-
-
4544355308
-
Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: A long-term survival analysis
-
Debby A, Levy T, Hayat H, et al. Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis. Int J Gynecol Cancer 2004; 14:794-798. Interesting trial evaluating a single fraction of abdominal radiation therapy for consolidation.
-
(2004)
Int J Gynecol Cancer
, vol.14
, pp. 794-798
-
-
Debby, A.1
Levy, T.2
Hayat, H.3
-
15
-
-
0141683287
-
Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment
-
Sorbe B. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 2003; 13:278-286.
-
(2003)
Int J Gynecol Cancer
, vol.13
, pp. 278-286
-
-
Sorbe, B.1
-
16
-
-
0041384504
-
32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: A randomized trial of the gynecologic oncology group
-
32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the gynecologic oncology group. J Clin Oncol 2003; 21:2849-2855.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2849-2855
-
-
Varia, M.A.1
Stehman, F.B.2
Bundy, B.N.3
-
17
-
-
4444383336
-
Randomized, placebo-controlled study of Oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer
-
Berek JS, Taylor PT, Gordon A, et al. Randomized, placebo-controlled study of Oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer. J Clin Oncol 2004; 22:3507-3516. A subgroup of CCR patients who might benefit from immunotherapy is identified.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3507-3516
-
-
Berek, J.S.1
Taylor, P.T.2
Gordon, A.3
-
18
-
-
4344703324
-
Maintenance treatment with interferon for advanced ovarian cancer: Results of the Northern and Yorkshire gynaecology group randomized phase III study
-
Hall GD, Brown JM, Coleman RE, et al. Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomized phase III study. Br J Cancer 2004; 91:621-626. Randomized trial showing no benefit to interferon over observation in consolidation.
-
(2004)
Br J Cancer
, vol.91
, pp. 621-626
-
-
Hall, G.D.1
Brown, J.M.2
Coleman, R.E.3
-
19
-
-
0742272538
-
Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer consolidative intraperitoneal cisplatin in ovarian cancer
-
Topuz E, Eralp Y, Saglam S, et al. Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer consolidative intraperitoneal cisplatin in ovarian cancer. Gynecol Oncol 2004; 92:147-151.
-
(2004)
Gynecol Oncol
, vol.92
, pp. 147-151
-
-
Topuz, E.1
Eralp, Y.2
Saglam, S.3
-
20
-
-
2442501421
-
Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: Results of a phase I/II trial
-
Sabbatini P, Aghajanian C, Leitao M, et al. Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial. Clin Cancer Res 2004; 10:2962-2967.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 2962-2967
-
-
Sabbatini, P.1
Aghajanian, C.2
Leitao, M.3
-
21
-
-
15444375965
-
Intraperitoneal hyperthermic chemotherapy in ovarian cancer
-
Gori J, Castano R, Toziano M, et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 2005; 15:233-239.
-
(2005)
Int J Gynecol Cancer
, vol.15
, pp. 233-239
-
-
Gori, J.1
Castano, R.2
Toziano, M.3
-
22
-
-
10044280462
-
Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer
-
Micha JP, Goldstein BH, Maittison JA, et al. Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer. Gynecol Oncol 2005; 96:132-135.
-
(2005)
Gynecol Oncol
, vol.96
, pp. 132-135
-
-
Micha, J.P.1
Goldstein, B.H.2
Maittison, J.A.3
|